Key role of Dkk3 protein in inhibition of cancer cell proliferation: An in silico identification

Journal of Theoretical Biology

Volumn 393, Issue , 2016, Pages 98-104

  Mohammadpour, Hemn ^a   Pourfathollah, Ali Akbar ^a   Nikougoftar Zarif, Mahin ^b   Khalili, Saeed ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

Author keywords

Bioinformatics; Cancer; Dkk; EGFR; Wnt signaling

Indexed keywords

CELL PROTEIN; DKK3 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOPROTEIN; KREMEN PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; PROTEIN BINDING; SIGNAL PEPTIDE;

BIOINFORMATICS; CANCER; INHIBITION; PROTEIN; TUMOR;

ACCURACY; ARTICLE; CANCER CELL; CANCER INHIBITION; COMPLEX FORMATION; COMPUTER MODEL; COMPUTER PROGRAM; CONTROLLED STUDY; MOLECULAR DOCKING; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; ANIMAL; CELL PROLIFERATION; CHEMISTRY; COMPUTER SIMULATION; HUMAN; METABOLISM; MOLECULAR GENETICS; MOLECULAR MODEL; MOUSE; NEOPLASM; PATHOLOGY; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; CELL PROLIFERATION; COMPUTER SIMULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEOPLASMS; PROTEIN BINDING; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84955459153     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2015.12.029     Document Type: Article

References (45)

1. Benkert P., Künzli M., Schwede T. QMEAN server for protein model quality estimation. Nucleic Acids Res. 2009, 37:510-514.
2. Bhattacharya D., Cheng J. 3Drefine: consistent protein structure refinement by optimizing hydrogen bonding network and atomic-level energy minimization. Proteins 2013, 81:119-131.
3. Chim C., Pang R., Liang R. Epigenetic dysregulation of the Wnt signalling pathway in chronic lymphocytic leukaemia. J. Clin. Pathol. 2008, 61:1214-1219.
4. Fiser A., Do R.K.G., Šali A. Modeling of loops in protein structures. Prot. Sci. 2000, 9:1753-1773.
5. Giles R.H., van Es J.H., Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta Rev. Cancer 2003, 1653:1-24.
6. Jahangiri A., Rasooli I., Rahbar M.R., Khalili S., Amani J., Zanoos K.A. Precise detection of L. monocytogenes hitting its highly conserved region possessing several specific antibody binding sites. J. Theor. Biol. 2012, 305:15-23.
7. Jang K.Y., Kim Y.N., Bae J.S., Chung M.J., Moon W.S., Kang M.J., Lee D.G., Park H.S. Expression of cyclin D1 is associated with β-catenin expression and correlates with good prognosis in colorectal adenocarcinoma. Transl. Oncol. 2012, 5:370-378.
8. Katase N., Gunduz M., Beder L., Gunduz E., Lefeuvre M., Hatipoglu O.F., Borkosky S.S., Tamamura R., Tominaga S., Yamanaka N. Deletion at Dickkopf (dkk)-3 locus (11p15. 2) is related with lower lymph node metastasis and better prognosis in head and neck squamous cell carcinomas. Oncol. Res. 2008, 17:273-282.
9. Kawano Y., Kypta R. Secreted antagonists of the Wnt signalling pathway. J. Cell Sci. 2003, 116:2627-2634.
10. Kawauchi K., Watanabe M., Kaku H., Huang P., Sasaki K., Sakaguchi M., Ochiai K., Huh N., Nasu Y., Kumon H. Preclinical safety and efficacy of in situ REIC/Dkk-3 gene therapy for prostate cancer. Acta Med. Okayama 2012, 66:7-16.
11. Khalili S., Rahbar M.R., Dezfulian M.H., Jahangiri A. In silico analyses of Wilms tumor protein to designing a novel multi-epitope DNA vaccine against cancer. J. Theor. Biol. 2015, 379:66-78.
12. Khalili S., Jahangiri A., Borna H., Ahmadi Zanoos K., Amani J. Computational vaccinology and epitope vaccine design by immunoinformatics. Acta Microbiol. Immunol. Hung. 2014, 61:285-307.
13. Kim B.M., Lee D.H., Choi H.J., Lee K.H., Kang S.J., Joe Y., Hong Y.K., Hong S.H. The recombinant kringle domain of urokinase plasminogen activator inhibits VEGF165-induced angiogenesis of HUVECs by suppressing VEGFR2 dimerization and subsequent signal transduction. IUBMB Life 2012, 64:259-265.
14. Kopp J., Schwede T. Automated protein structure homology modeling: a progress report. Pharmacogenomics 2004, 5:405-416.
15. Kozakov D., Brenke R., Comeau S.R., Vajda S. PIPER: an FFT-based protein docking program with pairwise potentials. Proteins 2006, 65:392-406.
16. Kozakov D., Beglov D., Bohnuud T., Mottarella S.E., Xia B., Hall D.R., Vajda S. How good is automated protein docking?. Proteins 2013, 81:2159-2166.
17. Kurose K., Sakaguchi M., Nasu Y., Ebara S., Kaku H., Kariyama R., Arao Y., Miyazaki M., Tsushima T., Namba M. Decreased expression of REIC/Dkk-3 in human renal clear cell carcinoma. J. Urol. 2004, 171:1314-1318.
18. Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 1993, 26:283-291.
19. Lu, K.H., 2014. On the regulation of T cell-dependent immune responses. 〈〉. http://www.ub.uni-heidelberg.de/archiv/17571.
20. Luu H.H., Zhang R., Haydon R.C., Rayburn E., Kang Q., Si W., Park J.K., Wang H., Peng Y., Jiang W. Wnt/β-catenin signaling pathway as novel cancer drug targets. Curr. Cancer. Drug Targets 2004, 4:653-671.
21. Lyskov S., Gray J.J. The RosettaDock server for local protein-protein docking. Nucleic Acids Res. 2008, 36:W233-W238.
22. Mashiach E., Schneidman-Duhovny D., Andrusier N., Nussinov R., Wolfson H.J. FireDock: a web server for fast interaction refinement in molecular docking. Nucleic Acids Res. 2008, 36:W229-W232. 10.1093/nar/gkn186.
23. Melo F., Feytmans E. Novel knowledge-based mean force potential at atomic level. J. Mol. Biol. 1997, 267:207-222.
24. Miller B.T., Singh R.P., Klauda J.B., Hodošček M., Brooks B.R., Woodcock Iii H.L. CHARMMing: a new, flexible web portal for CHARMM. J. Chem. Inf. Model. 2008, 48:1920-1929.
25. Mizobuchi Y., Matsuzaki K., Kuwayama K., Kitazato K., Mure H., Kageji T., Nagahiro S. REIC/Dkk-3 induces cell death in human malignant glioma. Neuro-oncology 2008, 10:244-253.
26. Mohammadpour H., Khalili S., Hashemi Z.S. Kremen is beyond a subsidiary co-receptor of Wnt signaling: an in silico validation. Turk. J. Biol. 2015, 39:501-510.
27. Mühlmann G., Untergasser G., Zitt M., Zitt M., Maier H., Mikuz G., Kronberger I.E., Haffner M.C., Gunsilius E., Öfner D. Immunohistochemically detectable dickkopf-3 expression in tumor vessels predicts survival in gastric cancer. Virchows Arch. 2010, 456:635-646.
28. Nakamura R.E., Hackam A.S. Analysis of Dickkopf3 interactions with Wnt signaling receptors. Growth Factors 2010, 28:232-242.
29. Nakamura R.E., Hunter D.D., Yi H., Brunken W.J., Hackam A.S. Identification of two novel activities of the Wnt signaling regulator Dickkopf 3 and characterization of its expression in the mouse retina. BMC Cell Biol. 2007, 8:52.
30. Niehrs C. Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 2006, 25:7469-7481.
31. Papatriantafyllou M., Moldenhauer G., Ludwig J., Tafuri A., Garbi N., Hollmann G., Kublbeck G., Klevenz A., Schmitt S., Pougialis G., Niehrs C., Grone H.J., Hammerling G.J., Arnold B., Oelert T. Dickkopf-3, an immune modulator in peripheral CD8 T-cell tolerance. Proc. Natl. Acad. Sci. 2012, 109:1631-1636. 10.1073/pnas.1115980109.
32. Paul I., Bhattacharya S., Chatterjee A., Ghosh M.K. Current understanding on EGFR and Wnt/β-catenin signaling in glioma and their possible crosstalk. Genes Cancer 2013, 4:427-446.
33. Persson B., Argos P. Topology prediction of membrane proteins. Protein Sci. 1996, 5:363-371. 10.1002/pro.5560050221.
34. Pierce B.G., Wiehe K., Hwang H., Kim B.-H., Vreven T., Weng Z. ZDOCK server: interactive docking prediction of protein-protein complexes and symmetric multimers. Bioinformatics 2014, 30:1771-1773.
35. Romero D., Kypta R. Dickkopf-3 function in the prostate: implications for epithelial homeostasis and tumor progression. Bioarchitecture 2013, 3:42-44. 19.
36. Roy A., Kucukural A., Zhang Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nat. Protoc. 2010, 5:725-738.
37. Sefid F., Rasooli I., Jahangiri A. In silico determination and validation of baumannii acinetobactin utilization a structure and ligand binding site. Biomed. Res. Int. 2013.
38. Uekita T., Sakai R. Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis. Cancer Sci. 2011, 102:1943-1948.
39. Ueno K., Hirata H., Majid S., Chen Y., Zaman M.S., Tabatabai Z.L., Hinoda Y., Dahiya R. Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma. Mol. Carcinog. 2011, 50:449-457.
40. Veeck J., Dahl E. Targeting the Wnt pathway in cancer: the emerging role of Dickkopf-3. Biochim. Biophys. Acta Rev. Cancer 2012, 1825:18-28.
41. Veeck J., Bektas N., Hartmann A., Kristiansen G., Heindrichs U., Knuchel R., Dahl E. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours. Breast Cancer Res. 2008, 10:R82.
42. Wang K., Zhang Y., Li X., Chen L., Wang H., Wu J., Zheng J., Wu D. Characterization of the Kremen-binding site on Dkk1 and elucidation of the role of Kremen in Dkk-mediated Wnt antagonism. J. Biol. Chem. 2008, 283:23371-23375.
43. Yang J., Yan R., Roy A., Xu D., Poisson J., Zhang Y. The I-TASSER Suite: protein structure and function prediction. Nat. Methods 2015, 12:7-8.
44. Yue W., Sun Q., Dacic S., Landreneau R.J., Siegfried J.M., Yu J., Zhang L. Downregulation of Dkk3 activates β-catenin/TCF-4 signaling in lung cancer. Carcinogenesis 2008, 29:84-92.
45. Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinform. 2008, 9:40. 10.1186/1471-2105-9-40.